Difference in age of onset of psychosis between epilepsy and schizophrenia

Epilepsy Research
Naoto AdachiTeiichi Onuma

Abstract

To clarify the nature of psychosis development in epilepsy patients, we studied differences in age of onset of psychosis between epilepsy patients with psychosis (epilepsy-psychosis) and schizophrenia patients. Subjects were 282 patients with epilepsy-psychosis (36 postictal, 224 interictal, and 22 bimodal psychoses) and 612 schizophrenia patients. Age of onset was compared between the schizophrenia group and the whole epilepsy-psychosis group as well as its subgroups. Effects of sex and family history of psychosis on age of onset were also evaluated. Epilepsy patients developed psychosis later (mean age 30.1) than schizophrenia patients (mean age 26.6). Among epilepsy-psychosis subgroups, postictal psychosis and interictal psychosis showed a later onset than schizophrenia. In interictal psychosis, while chronic schizophrenia-like psychosis occurred at similar age compared to schizophrenia, brief episodic psychosis occurred at later age. Epilepsy-psychosis patients showed no sex difference in age of onset, whereas female schizophrenia patients showed a later onset than male schizophrenia patients. Both the epilepsy and schizophrenia patients with family history of psychosis tended to develop psychosis at an earlier age, althoug...Continue Reading

References

Jan 1, 1992·Psychological Medicine. Monograph Supplement·A JablenskyA Bertelsen
Sep 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·M Deahl, M Trimble
Feb 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·S J Logsdail, B K Toone
May 1, 1986·Archives of General Psychiatry·M M WeissmanD L Pauls
Apr 1, 1983·Journal of Neurology, Neurosurgery, and Psychiatry·J Dana-HaeriJ Oxley
Feb 1, 1995·The American Journal of Psychiatry·P GorwoodJ Feingold
Jun 1, 1993·Neurology·M F MendezJ L Taylor
Aug 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·K S KendlerD Walsh
Oct 1, 1996·Epilepsy Research·O C CockerellS D Shorvon
Mar 21, 1998·The American Journal of Psychiatry·P Sachdev
Jun 6, 1998·The British Journal of Psychiatry : the Journal of Mental Science·S R BredkjaerJ Parnas
Dec 16, 1998·The British Journal of Psychiatry : the Journal of Mental Science·J D MellersW A Lishman
Nov 23, 2000·Neurology·N AdachiT Onuma
Jan 1, 1963·The British Journal of Psychiatry : the Journal of Mental Science·E SLATERE GLITHERO
Mar 28, 2007·Epilepsia·Naoto AdachiTeiichi Onuma

❮ Previous
Next ❯

Citations

Mar 14, 2009·The Neurologist·Irene García-MoralesAndrés M Kanner
Mar 3, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Naoto AdachiTeiichi Onuma
Dec 1, 2009·The Psychiatric Clinics of North America·Arman Danielyan, Henry A Nasrallah
Feb 25, 2009·Epilepsy & Behavior : E&B·Luciana D'AlessioSilvia Kochen
Jun 5, 2019·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Bing CaoJingyu Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved